title: Recent advances and future perspectives in the management of lung cancer.
authors.affiliation: Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Alexander Sasha
authors.initials: AS
authors.lastname: Krupnick
authors.forename: Daniel
authors.initials: D
authors.lastname: Kreisel
authors.forename: Andrew
authors.initials: A
authors.lastname: Hope
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Bradley
authors.forename: Ramaswamy
authors.initials: R
authors.lastname: Govindan
authors.forename: Bryan
authors.initials: B
authors.lastname: Meyers
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D005544:Forecasting; D000077156:Gefitinib; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D016040:Lung Transplantation; D008403:Mass Screening; D020360:Neoadjuvant Therapy / Q000379:methods; D009367:Neoplasm Staging; D011013:Pneumonectomy; D011799:Quinazolines / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D021701:Sentinel Lymph Node Biopsy; D012907:Smoking / Q000009:adverse effects
chemical_list: D007376:Interleukin-2; D011799:Quinazolines; D000077156:Gefitinib